摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(S)-(2l,6l)-3-(1,1-Dimethylethyl)-6-methyl-2-(2-propenyl)-1,3,2-oxazaphosphorinane 2-oxide | 173007-80-2

中文名称
——
中文别名
——
英文名称
(S)-(2l,6l)-3-(1,1-Dimethylethyl)-6-methyl-2-(2-propenyl)-1,3,2-oxazaphosphorinane 2-oxide
英文别名
(2S,6S)-3-tert-butyl-6-methyl-2-prop-2-enyl-1,3,2lambda5-oxazaphosphinane 2-oxide;(2S,6S)-3-tert-butyl-6-methyl-2-prop-2-enyl-1,3,2λ5-oxazaphosphinane 2-oxide
(S)-(2l,6l)-3-(1,1-Dimethylethyl)-6-methyl-2-(2-propenyl)-1,3,2-oxazaphosphorinane 2-oxide化学式
CAS
173007-80-2
化学式
C11H22NO2P
mdl
——
分子量
231.275
InChiKey
RADGBBRUAQHVPD-BONVTDFDSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    279.1±33.0 °C(Predicted)
  • 密度:
    1.01±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1.8
  • 重原子数:
    15
  • 可旋转键数:
    3
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.82
  • 拓扑面积:
    29.5
  • 氢给体数:
    0
  • 氢受体数:
    3

反应信息

  • 作为反应物:
    描述:
    2-环戊烯酮(S)-(2l,6l)-3-(1,1-Dimethylethyl)-6-methyl-2-(2-propenyl)-1,3,2-oxazaphosphorinane 2-oxidecopper(l) iodide正丁基锂 作用下, 以 四氢呋喃正戊烷 为溶剂, 反应 1.0h, 以77%的产率得到(S)-(2l,6l,3''x)-(1'E)-2-<3'-(3''-Oxocyclopentyl)-1'-propenyl>-3-(1,1-dimethylethyl)-6-methyl-1,3,2-oxazaphosphorinane 2-oxide
    参考文献:
    名称:
    Asymmetric Michael Addition Reaction of Phosphorus-Stabilized Allyl Anions with Cyclic Enones
    摘要:
    The asymmetric Michael addition reaction of chirally modified P-allyl anions derived from enantiomerically enriched 2-allyl-1,3,2-oxazaphosphorinane 2-oxides has been investigated with cyclic enones. The racemic 1,3,2-oxazaphosphorinane 2-oxide 3 has been shown to be extremely diastereoselective in the Michael addition to 5-, 6-, and 7-ring enones. With the enantiomerically enriched 2-allyl-1,3,2-oxazaphosphorinane 2-oxides, high regio- and diastereoselectivities (88-90% diastereomeric excess) have been achieved in the Michael addition reaction of one of the diastereomers (cis series). The Michael reaction of the anions derived from the trans series were not diastereoselective (similar to 10% diastereomeric excess). The origin of the addition selectivity can be rationalized by (1) consideration of the structure and conformational preferences of the allyl anion (parallel conformation, s-trans, no lithium contact), (2) conformational analysis of the 1,3,2-oxazaphosphorinane 2-oxide ring (chair, equatorial allyl group) and (3) assumption of a 10-membered ring transition state structure with lithium coordination of the enone.
    DOI:
    10.1021/jo00128a028
  • 作为产物:
    参考文献:
    名称:
    Asymmetric Michael Addition Reaction of Phosphorus-Stabilized Allyl Anions with Cyclic Enones
    摘要:
    The asymmetric Michael addition reaction of chirally modified P-allyl anions derived from enantiomerically enriched 2-allyl-1,3,2-oxazaphosphorinane 2-oxides has been investigated with cyclic enones. The racemic 1,3,2-oxazaphosphorinane 2-oxide 3 has been shown to be extremely diastereoselective in the Michael addition to 5-, 6-, and 7-ring enones. With the enantiomerically enriched 2-allyl-1,3,2-oxazaphosphorinane 2-oxides, high regio- and diastereoselectivities (88-90% diastereomeric excess) have been achieved in the Michael addition reaction of one of the diastereomers (cis series). The Michael reaction of the anions derived from the trans series were not diastereoselective (similar to 10% diastereomeric excess). The origin of the addition selectivity can be rationalized by (1) consideration of the structure and conformational preferences of the allyl anion (parallel conformation, s-trans, no lithium contact), (2) conformational analysis of the 1,3,2-oxazaphosphorinane 2-oxide ring (chair, equatorial allyl group) and (3) assumption of a 10-membered ring transition state structure with lithium coordination of the enone.
    DOI:
    10.1021/jo00128a028
点击查看最新优质反应信息

文献信息

  • Asymmetric Michael Addition Reaction of Phosphorus-Stabilized Allyl Anions with Cyclic Enones
    作者:Scott E. Denmark、Jung-Ho Kim
    DOI:10.1021/jo00128a028
    日期:1995.11
    The asymmetric Michael addition reaction of chirally modified P-allyl anions derived from enantiomerically enriched 2-allyl-1,3,2-oxazaphosphorinane 2-oxides has been investigated with cyclic enones. The racemic 1,3,2-oxazaphosphorinane 2-oxide 3 has been shown to be extremely diastereoselective in the Michael addition to 5-, 6-, and 7-ring enones. With the enantiomerically enriched 2-allyl-1,3,2-oxazaphosphorinane 2-oxides, high regio- and diastereoselectivities (88-90% diastereomeric excess) have been achieved in the Michael addition reaction of one of the diastereomers (cis series). The Michael reaction of the anions derived from the trans series were not diastereoselective (similar to 10% diastereomeric excess). The origin of the addition selectivity can be rationalized by (1) consideration of the structure and conformational preferences of the allyl anion (parallel conformation, s-trans, no lithium contact), (2) conformational analysis of the 1,3,2-oxazaphosphorinane 2-oxide ring (chair, equatorial allyl group) and (3) assumption of a 10-membered ring transition state structure with lithium coordination of the enone.
查看更多

同类化合物

曲磷胺 曲磷胺 异环磷酰胺杂质F 异环磷酰胺 [(2-羟基-2-氧代-1,4,2-氧氮杂磷杂环己烷-4-基)甲基]膦酸 4-过氧化氢异环磷酰胺 4-氧代异环磷酰胺 4-乙基-7-甲基-7-氮杂-2,6-二氧杂-1-磷杂双环[2.2.2]辛烷1-硫化物 2’-氧代异环磷酰胺 2-[2-氯乙基-[3-(2-氯乙基)-2-氧代-1-氧杂-3-氮杂-2-磷杂环己-2-基]氨基]乙基甲烷磺酸酯 2,3,4,6,7,8-六氢-[1,3,2]氧氮杂膦咛并[2,3-b][1,3,2]氧氮杂膦咛 (2-氯-乙基)-[(R)-3-(2-氯-乙基)-2-氧代-2lambda5-[1,3,2]氧氮杂磷杂环己烷-2-基]-胺 (2R*,4aS*,8aR*)-1-methyl-2-phenyl-1,4,4a,5,6,7,8,8a-octahydro-2H-3,1,2-benzoxazaphosphinine 2-oxide (2S*,4aS*,8aR*)-2-phenyl-1,4,4a,5,6,7,8,8a-octahydro-2H-3,1,2-benzoxazaphosphinine 2-oxide (2R*,4aS*,8aS*)-1-methyl-2-phenyl-1,4,4a,5,6,7,8,8a-octahydro-2H-3,1,2-benzoxazaphosphinine 2-oxide (2S*,4aS*,8aS*)-2-phenyl-1,4,4a,5,6,7,8,8a-octahydro-2H-3,1,2-benzoxazaphosphinine 2-oxide (S,S)-2-oxo-2-propionyl-1,3,2-oxaphosphorinane 2-(Dimethylamino)-3-phenyl-1,3,2-oxazaphosphorinane 2-(1,1,1,3,3,3-Hexafluoroisopropoxy)-3,5,5-trimethyl-1,3,2-oxazaphosphorinane cis-2-(1,1,1,3,3,3-Hexafluoroisopropoxy)-3-methyl-5-tert-butyl-1,3,2-oxazaphosphorinane 2-(1,1,1,3,3,3-Hexafluoroisopropoxy)-3-methyl-1,3,2-oxazaphosphorinane 2-(1,1,1,3,3,3-Hexafluoroisopropoxy)-3-phenyl-1,3,2-oxazaphosphorinane 3,3,5,5-tetramethyl-2-oxido-2-oxo-1,4,2-oxaazaphosphorinane 2-(2-chloroethylamino)-3-(1-methyl-2-chloroethyl)tetrahydro-2H-1,3,2-oxazaphosphorine 2-oxide 4-ethyl-2-hydroxy-2-oxo-tetrahydro-4H-1,4,2-oxazaphosphorine geranyloxyifosfamide 4-methoxy-ifosfamide (2-chloroethyl)-[3-(2-chloroethyl)-2-oxo-4-pentyloxy-2λ5-[1,3,2]oxazaphosphinan-2-yl]amine 3-ethyl-2-hydroxy-2-oxo-1,4,2-oxazaphosphorinane Methyl-[3-(3-methyl-[1,3,2]oxazaphosphinan-2-yloxy)-propyl]-amine 2-Oxo-3-(propan-2-yl)-1,3,2-oxazaphosphinan-2-ium 3-(2-Chloroethyl)-2-(2-chloroethyl)amino-4-hydroxytetrahydro-2H-1,3,2-oxazaphosphorine 3-(2-Chloroethyl)-2-(1-ethyl-2-mesyloxyethylamino)-tetrahydro-2H-1,3,2-oxazaphosphorin-2-oxide 2H-1,3,2-Oxazaphosphorine, 2-fluorotetrahydro-3,5-dimethyl-, 2-oxide 2H-1,3,2-Oxazaphosphorine, 2-fluorotetrahydro-3,4-dimethyl-, 2-oxide (3-Isopropyl-2-oxo-2λ5-[1,3,2]oxazaphosphinan-2-yl)-acetic acid methyl ester cis-2-mesityl-2-oxo-3-phenyl-5-tert-butyl-1,3,2λ5-oxazaphosphorinane trans-2-mesityl-2-oxo-3-phenyl-5-tert-butyl-1,3,2λ5-oxazaphosphorinane (2S,6S)-2-Benzyl-3-(1,1-diethyl-propyl)-6-methyl-[1,3,2]oxazaphosphinane 2-oxide (2R,6S)-2-Benzyl-3-(1,1-diethyl-propyl)-6-methyl-[1,3,2]oxazaphosphinane 2-oxide (2S,6S)-2-((E)-2-Allyloxy-but-2-enyl)-3-tert-butyl-6-methyl-[1,3,2]oxazaphosphinane 2-oxide (2R,6S)-2-((E)-2-Allyloxy-but-2-enyl)-3-tert-butyl-6-methyl-[1,3,2]oxazaphosphinane 2-oxide (S)-(2l,6l)-2-(methoxymethyl)-6-methyl-3-(1-methylethyl)-1,3,2-oxazaphosphorinane 2-sulfide (S)-1-((2S,6S)-3-tert-Butyl-6-methyl-2-oxo-2λ5-[1,3,2]oxazaphosphinan-2-yl)-3-methyl-hex-5-en-2-one 2-methoxy-1,3,2-oxazaphosphinane 3-(2-Chloroethyl-2-<(2-chloroethyl)-(3-mesyloxytrimethylen)-amino>-tetrahydro-2H-1,3,2-oxazaphosphorin-2-oxide 2-chloro-3-[(S)-α-methylbenzyl]tetrahydro-2H-1,3,2-oxazaphosphorine 2-oxide (S)-(2u,6l)-3-(1,1-Diethylpropyl)-6-methyl-2-(2-propenyl)-1,3,2-oxazaphosphorinane 2-oxide 3-(2-chloro-ethyl)-2-(2-hydroxy-ethylamino)-2-oxo-2λ5-[1,3,2]oxazaphosphinan-4-one isopropyl-[3-(3-isopropyl-[1,3,2]oxazaphosphinan-2-yloxy)-propyl]-amine